Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | AZN | AMGN | GILD | BMY |
| Company | Fate Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.3300 | 196.72 | 376.17 | 147.73 | 60.60 |
| High | 1.3800 | 198.09 | 378.97 | 149.26 | 60.81 |
| Low | 1.3300 | 195.97 | 372.74 | 146.84 | 59.98 |
| Latest | 1.3550 | 197.83 | 378.13 | 148.85 | 60.89 |
| Change | +0.0250 | +2.88 | +1.16 | +2.22 | +0.26 |
| % Change | +1.88% | +1.48% | +0.31% | +1.51% | +0.43% |
| Volume | 565,968 | 708,404 | 850,923 | 1,238,322 | 2,751,963 |
| 20-Day Average Volume | 1,657,543 | 2,155,162 | 2,582,490 | 7,156,731 | 12,395,636 |
| Previous Close | 1.3300 | 194.95 | 376.97 | 146.63 | 60.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3813 | 203.00 | 375.86 | 149.41 | 60.91 |
| 20-Day Raw Stochastic | 42.40% | 33.78% | 53.04% | 41.74% | 36.65% |
| 20-Day Relative Strength | 51.75 | 51.17 | 57.05 | 56.85 | 56.77 |
| Weighted Alpha | +4.66 | +33.25 | +29.00 | +41.30 | +15.44 |
| Today's Opinion | 88% Buy | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 88% Buy | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 32% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.55% since 03/03/26 | -2.24% since 03/03/26 | +0.02% since 03/03/26 | +0.68% since 03/03/26 | -1.06% since 03/03/26 |
| Low | 1.2601 on 03/06/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 1.4800 on 03/04/26 | 203.29 on 03/04/26 | 380.09 on 03/04/26 | 149.26 on 03/10/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | +22.48% since 02/10/26 | +1.99% since 02/10/26 | +3.40% since 02/10/26 | +1.09% since 02/10/26 | -0.48% since 02/10/26 |
| Low | 1.0700 on 02/11/26 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 1.6950 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +22.48% since 12/10/25 | +7.77% since 12/10/25 | +19.56% since 12/10/25 | +22.66% since 12/10/25 | +18.28% since 12/10/25 |
| Low | 0.9510 on 12/23/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.44 on 12/11/25 |
| High | 1.6950 on 02/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +33.50% since 09/10/25 | +22.04% since 09/10/25 | +35.39% since 09/10/25 | +29.14% since 09/10/25 | +28.46% since 09/10/25 |
| Low | 0.9401 on 09/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.9399 on 10/27/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 154,630 | 302,349,504 | 203,212,464 | 182,029,584 | 123,471,424 |
| Shares Outstanding, K | 116,263 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 6,650,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -136,320,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,370,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -32,370,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.18 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/13/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/12/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.20 | 16.91 | 17.66 | 9.80 |